NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Therapy



Anastrozole improves lipid profiles of older Japanese women with breast cancer



May 26th, 2005

Anastrozole was found to have a positive affect on lipid profiles of postmenopausal Japanese women with early-stage breast cancer.

"Endocrine therapies that profoundly decrease estrogen levels potentially have a detrimental effect on the cardiovascular system. This study evaluated the effect on lipid metabolism of one such agent, the new generation aromatase inhibitor anastrozole, compared with tamoxifen, when used as adjuvant treatment in postmenopausal Japanese women with early breast cancer," said S. Sawada and colleagues at Japan's National Defense Medical College, Saitama.

The 44 study participants had undergone primary surgery "and were...


Source: Women's Health Weekly (2005-05-26)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login